Sources of endogenous glucose production in the Goto-Kakizaki diabetic rat

Diabetes and Metabolism

Volumn 33, Issue 4, 2007, Pages 296-302

  Sena, C M ^a   Barosa, C ^b   Nunes, E ^a   Seica R ^a   Jones, J G ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

U 13C glucose; Endogenous glucose production; Gluconeogenesis; Goto Kakizaki rats; Type 2 diabetes; Wistar rats

Indexed keywords

CARBON 13; GLUCOSE; GLYCEROL; INSULIN; PHOSPHOENOLPYRUVATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DEUTERON NUCLEAR MAGNETIC RESONANCE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCOGENOLYSIS; GOTO KAKIZAKI DIABETIC RAT; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; RAT STRAIN; WISTAR RAT; ANIMAL; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANIMALS; BLOOD GLUCOSE; GLUCOSE; GLYCEROL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; RATS, INBRED STRAINS; RATS, WISTAR;

EID: 34548695455     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.03.002     Document Type: Article

References (41)

1. Goto Y.-I., Sasaki M., Ono T., and Abe S. GK rat as a model of nonobese, noninsulin dependent diabetes: selective breeding over 35 generations. Frontiers in diabetes research. Lessons from animal diabetes II (1988), John Libbey, London
2. Goto Y., Kakizaki M., and Masaki N. Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc. Jpn. Acad. 51 (1975) 80-85
3. Kimura K., Toyota T., Kakizaki M., Kudo M., Takebe K., and Goto Y. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J. Exp. Med. 137 (1982) 453-459
4. Picarel-Blanchot F., Berthelier C., Bailbe D., and Portha B. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat. Am. J. Physiol. 271 (1996) E755-E762
5. Boden G., Chen X., and Stein T.P. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am. J. Physiol. 280 (2001) E23-E30
6. Gastaldelli A., Baldi S., Pettiti M., Toschi E., Camastra S., Natali A., et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans. a quantitative study. Diabetes 49 (2000) 1367-1373
7. 13C]glucose study. Am. J. Physiol. 270 (1996) E709-E717
8. Landau B.R., Wahren J., Chandramouli V., Schumann W.C., Ekberg K., and Kalhan S.C. Contributions of gluconeogenesis to glucose production in the fasted state. J. Clin. Invest. 98 (1996) 378-385
9. 2O for quantification of hepatic glucose production and gluconeogenesis. NMR Biomed. 16 (2003) 189-198
10. Katz J., and Tayek J.A. Recycling of glucose and determination of the Cori cycle and gluconeogenesis. Am. J. Physiol. 277 (1999) E401-E407
11. 13C]glucose. Am. J. Physiol. 278 (2000) E140-E145
12. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrin & Metab 85 (2000) 2402-2410
13. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment-insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
14. 13C NMR of urinary menthol glucuronide. Magn Res Med 56 (2006) 1121-1125
15. 2H NMR analysis of plasma glucose. Biochim Biophys Acta-Molecular Basis of Disease 1637 (2003) 156-163
16. 13C NMR study of gluconeogenesis and TCA cycle flux in humans. Am. J. Physiol. 281 (2001) E848-E851
17. 13C NMR in patients with HIV-associated lipoatrophy. Magn Res Med 51 (2004) 649-654
18. Mithieux G., Gautier-Stein A., Rajas F., and Zitoun C. Contribution of intestine and kidney to glucose fluxes in different nutritional states in rat. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 143 (2006) 195-200
19. Kleiber M., Smith A.H., and Chernikoff T.N. Metabolic rate of female rats as a function of age and body size. Am. J. Physiol. 186 (1956) 9-12
20. Neese R.A., Schwarz J.M., Faix D., Turner S., Letscher A., Vu D., et al. Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems. J. Biol. Chem. 270 (1995) 14452-14466
21. Vore S.J., Aycock E.D., Veldhuis J.D., and Butler P.C. Anesthesia rapidly suppresses insulin pulse mass but enhances the orderliness of insulin secretory process. Am. J. Physiol. 281 (2001) E93-E99
22. van Poelje P.D., Potter S.C., Chandramouli V.C., Landau B.R., Dang Q., and Erion M.D. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycaemia in Zucker diabetic fatty rats. Diabetes 55 (2006) 1747-1754
23. Jin E.S., Burgess S.C., Merritt M.E., Sherry A.D., and Malloy C.R. Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose. Am. J. Physiol. 288 (2005) E654-E662
24. 2H in plasma glucose: comparison of nuclear magnetic resonance and mass spectrometry. Anal. Biochem. 318 (2003) 321-324
25. 13C NMR isotopomer analysis of human urine. Anal. Biochem. 312 (2003) 228-234
26. Stingl H., Chandramouli V., Schumann W.C., Brehm A., Nowotny P., Waldhausl W., et al. Changes in hepatic glycogen cycling during a glucose load in healthy humans. Diabetologia 49 (2006) 360-368
27. 2O. Anal. Biochem. 277 (2000) 121-126
28. Rose I., and O'Connell E.L. Stereospecificity of the sugar-phosphate isomerase reactions-a uniformity. Biochim. Biophys. Acta 42 (1960) 159-160
29. Chandramouli V., Ekberg K., Schumann W.C., Wahren J., and Landau B.R. Origins of the hydrogen bound to carbon 1 of glucose in fasting: significance in gluconeogenesis quantitation. Am. J. Physiol. 277 (1999) E717-E723
30. Diraison F., Large V., Brunengraber H., and Beylot M. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM. Diabetologia 41 (1998) 212-220
31. Tappy L., Acheson K., Curchod B., Schneiter P., Normand S., Pachiaudi C., et al. Overnight glucose-metabolism in obese non-insulin-dependent diabetic-patients and in healthy lean individuals. Clin. Physiol. 14 (1994) 251-265
32. 13C]glucose study. Am. J. Physiol. 270 (1996) E709-E717
33. Chevalier S., Burgess S.C., Malloy C.R., Gougeon R., Marliss E.B., and Morais J.A. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55 (2006) 675-681
34. Gastaldelli A., Miyazaki Y., Pettiti M., Buzzigoli E., Mahankali S., Ferrannini E., et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J. Clin. Endocrinol. Metab. 89 (2005) 3914-3921
35. Basu R., Chandramouli V., Dicke B., Landau B., and Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54 (2005) 1942-1948
36. Pickavance L.C., Brand C.L., Wassermann K., and Wilding J.P. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. Br. J. Pharmacol. 144 (2005) 308-316
37. Thulé P.M., Campbell A.G., Kleinhenz D.J., Olson D.E., Boutwell J.J., Sutliff R.L., et al. Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats. Am. J. Physiol. 290 (2006) E114-E122
38. Berthelier C., Kergoat M., and Portha B. Lack of deterioration of insulin action with aging in the GK rat: a contrasted adaptation as compared with nondiabetic rats. Metabolism 46 (1997) 890-896
39. Bisbis S., Bailbe D., Tormo M.A., Picarel-Blanchot F., Derouet M., Simon J., et al. Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver. Am. J. Physiol. 265 (1993) E807-E813
40. Seiça R.M., Suzuki K.I., Santos R.M., and Rosário L.M. Impaired insulin secretion in isolated islets of Goto-Kakizaki rats, an animal model of non obese type 2 diabetes, is a primary event. Acta Med. Port. 17 (2004) 42-48
41. Saha J.K., Xia J., Engle S.K., Chen Y.F., Glaesner W., and Jakubowski J.A. A model of controlled acute hyperglycaemia in rats: effects of insulin and glucagon-like peptide-1 analog. J. Pharmacol. Exp. Ther. 316 (2006) 1159-1164